Literature DB >> 8633856

Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora.

T L Miller1, M J Wolin.   

Abstract

The pathways of short-chain fatty acid (SCFA; acetate, propionate, and butyrate) formation from glucose were determined for the human fecal microbial communities of two subjects. The pathways were identified by radioisotope analysis of the SCFA and CO2 obtained after incubation of fecal suspensions with glucose under 20% CO2 with [1-14C]glucose, [3,4-14C]glucose, or 14CO2. Acetate was chemically degraded to learn the labeling of the methyl and carboxyl carbons. The labeling of CO2 and acetate showed that the major route of glucose catabolism was the Embden-Meyerhof-Parnas pathway, with production of CO2 from pyruvate carboxyl carbon. Labeling of the methyl and carboxyl carbons of acetate by 14CO2 or [3,4-14C]glucose proved that acetate was formed from CO2 by the Wood-Ljungdahl pathway. CO2 reduction accounted for about one-third of the acetate formed by suspensions from subject 1 and about one-fourth of the acetate formed by suspensions from subject 2. Propionate was formed by a CO2 fixation pathway, and butyrate was formed by classical routes of acetyl-S coenzyme A condensation. The amount of CO2 formed from [1-14C] glucose and acetate labeling patterns obtained with the other 14C precursors indicated that the Entner-Doudoroff, transketolase-transaldolase, and heterolactic pathways were not significant. Fermentation of cabbage cellulose by subject 1 followed the same pathways as were used for glucose. The results with suspensions from subject 2 suggested that some radioactive acetate was formed from the C-3 of glucose by the Bifidobacterium pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8633856      PMCID: PMC167932          DOI: 10.1128/aem.62.5.1589-1592.1996

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  16 in total

Review 1.  Clinical significance of colonic fermentation.

Authors:  D Royall; T M Wolever; K N Jeejeebhoy
Journal:  Am J Gastroenterol       Date:  1990-10       Impact factor: 10.864

2.  Fermentation of Insoluble Cellulose by Continuous Cultures of Ruminococcus albus.

Authors:  S G Pavlostathis; T L Miller; M J Wolin
Journal:  Appl Environ Microbiol       Date:  1988-11       Impact factor: 4.792

3.  A serum bottle modification of the Hungate technique for cultivating obligate anaerobes.

Authors:  T L Miller; M J Wolin
Journal:  Appl Microbiol       Date:  1974-05

4.  Interaction between colonic acetate and propionate in humans.

Authors:  T M Wolever; P Spadafora; H Eshuis
Journal:  Am J Clin Nutr       Date:  1991-03       Impact factor: 7.045

5.  Utilization of nutrients by isolated epithelial cells of the rat colon.

Authors:  W E Roediger
Journal:  Gastroenterology       Date:  1982-08       Impact factor: 22.682

6.  Intestinal floras of populations that have a high risk of colon cancer.

Authors:  W E Moore; L H Moore
Journal:  Appl Environ Microbiol       Date:  1995-09       Impact factor: 4.792

Review 7.  Effects of sodium butyrate, a new pharmacological agent, on cells in culture.

Authors:  J Kruh
Journal:  Mol Cell Biochem       Date:  1982-02-05       Impact factor: 3.396

8.  Cornstarch fermentation by the colonic microbial community yields more butyrate than does cabbage fiber fermentation; cornstarch fermentation rates correlate negatively with methanogenesis.

Authors:  G A Weaver; J A Krause; T L Miller; M J Wolin
Journal:  Am J Clin Nutr       Date:  1992-01       Impact factor: 7.045

9.  Acetate production from hydrogen and [13C]carbon dioxide by the microflora of human feces.

Authors:  S F Lajoie; S Bank; T L Miller; M J Wolin
Journal:  Appl Environ Microbiol       Date:  1988-11       Impact factor: 4.792

10.  Effects of 1,25-dihydroxyvitamin D3 and its analogs on butyrate-induced differentiation of HT-29 human colonic carcinoma cells and on the reversal of the differentiated phenotype.

Authors:  Y Tanaka; K K Bush; T Eguchi; N Ikekawa; T Taguchi; Y Kobayashi; P J Higgins
Journal:  Arch Biochem Biophys       Date:  1990-02-01       Impact factor: 4.013

View more
  100 in total

1.  Promising discovery of beneficial Escherichia coli in the human gut.

Authors:  Atchareeya Nakkarach; Hooi Ling Foo; Adelene Ai-Lian Song; Sunee Nitisinprasert; Ulaiwan Withayagiat
Journal:  3 Biotech       Date:  2020-06-09       Impact factor: 2.406

2.  Prolonged antibiotic use induces intestinal injury in mice that is repaired after removing antibiotic pressure: implications for empiric antibiotic therapy.

Authors:  Lindsey E Romick-Rosendale; Anne Legomarcino; Neil B Patel; Ardythe L Morrow; Michael A Kennedy
Journal:  Metabolomics       Date:  2014-02       Impact factor: 4.290

3.  Validated Postbiotic Screening Confirms Presence of Physiologically-Active Metabolites, Such as Short-Chain Fatty Acids, Amino Acids and Vitamins in Hylak® Forte.

Authors:  Satish Patil; Sarvesh Sawant; Karlheinz Hauff; Gabriele Hampp
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

Review 4.  Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.

Authors:  Aonghus Lavelle; Harry Sokol
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-02-19       Impact factor: 46.802

Review 5.  Prebiotics: tools to manipulate the gut microbiome and metabolome.

Authors:  Fatima Enam; Thomas J Mansell
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-14       Impact factor: 3.346

6.  Description of the bacterial microbiota of anal sacs in healthy dogs.

Authors:  Camylle C Bergeron; Marcio C Costa; Lucilene B de Souza; Frédéric Sauvé
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

Review 7.  The gut microbiota, bacterial metabolites and colorectal cancer.

Authors:  Petra Louis; Georgina L Hold; Harry J Flint
Journal:  Nat Rev Microbiol       Date:  2014-09-08       Impact factor: 60.633

8.  Phylogenetic and functional alterations in bacterial community compositions in broiler ceca as a result of mannan oligosaccharide supplementation.

Authors:  A Corrigan; Marcel de Leeuw; Stéphanie Penaud-Frézet; Diliana Dimova; R A Murphy
Journal:  Appl Environ Microbiol       Date:  2015-03-13       Impact factor: 4.792

9.  Low iron availability in continuous in vitro colonic fermentations induces strong dysbiosis of the child gut microbial consortium and a decrease in main metabolites.

Authors:  Alexandra Dostal; Sophie Fehlbaum; Christophe Chassard; Michael B Zimmermann; Christophe Lacroix
Journal:  FEMS Microbiol Ecol       Date:  2012-08-28       Impact factor: 4.194

10.  Dissecting the in vivo metabolic potential of two human gut acetogens.

Authors:  Federico E Rey; Jeremiah J Faith; James Bain; Michael J Muehlbauer; Robert D Stevens; Christopher B Newgard; Jeffrey I Gordon
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.